Hybrid immune cells in early-stage lung cancer spur anti-tumor T cells to action

(University of Pennsylvania School of Medicine) Researchers have identified a unique subset of these cells that exhibit hybrid characteristics of two immune cell types -- neutrophils and antigen-presenting cells -- in samples from early-stage human lung cancers. This is the first study to describe this phenomenon in a human tumor.